4//SEC Filing
Appelbaum Kevin J 4
Accession 0000899243-21-046974
CIK 0001832415other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:34 PM ET
Size
9.8 KB
Accession
0000899243-21-046974
Insider Transaction Report
Form 4
Appelbaum Kevin J
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-12-03$6.43/sh+500$3,213→ 1,000 total - Purchase
Common Stock
2021-12-02$6.84/sh+500$3,420→ 500 total
Holdings
- 2,406,719(indirect: By Trust)
Common Stock
Transactions
- Purchase
Common Stock
2021-12-02$6.84/sh+500$3,420→ 500 total - Purchase
Common Stock
2021-12-03$6.43/sh+500$3,213→ 1,000 total
Holdings
- 2,406,719(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.440 to $6.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001547557
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 5:34 PM ET
- Size
- 9.8 KB